Suppr超能文献

尼帕病毒:在当前严重急性呼吸综合征冠状病毒2大流行背景下的一种潜在大流行病原体。

Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic.

作者信息

Devnath P, Masud H M A A

机构信息

Department of Microbiology, Faculty of Sciences, Noakhali Science and Technology University, Noakhali, Bangladesh.

Department of Microbiology, Faculty of Biological Sciences, University of Chittagong, Chattogram, Bangladesh.

出版信息

New Microbes New Infect. 2021 May;41:100873. doi: 10.1016/j.nmni.2021.100873. Epub 2021 Mar 19.

Abstract

For centuries, zoonotic diseases have been responsible for various outbreaks resulting in the deaths of millions of people. The best example of this is the current coronavirus disease 2019 (COVID-19) pandemic. Like severe acute respiratory syndrome coronavirus, Nipah virus is another deadly virus which has caused several outbreaks in the last few years. Though it causes a low number of infections, disease severity results in a higher death rate. In the context of the recent COVID-19 pandemic, we speculate that many countries will be unable to deal with the sudden onset of such a viral outbreak. Thus, further research and attention to the virus are needed to address future outbreaks.

摘要

几个世纪以来,人畜共患疾病一直是导致各种疫情爆发的原因,造成了数百万人死亡。当前的2019冠状病毒病(COVID-19)大流行就是最好的例子。与严重急性呼吸综合征冠状病毒一样,尼帕病毒是另一种致命病毒,在过去几年中引发了几次疫情。虽然它导致的感染数量较少,但疾病的严重性导致了更高的死亡率。在最近的COVID-19大流行背景下,我们推测许多国家将无法应对这种病毒爆发的突然发生。因此,需要对该病毒进行进一步研究并予以关注,以应对未来的疫情爆发。

相似文献

1
Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic.
New Microbes New Infect. 2021 May;41:100873. doi: 10.1016/j.nmni.2021.100873. Epub 2021 Mar 19.
2
Emerging zoonotic diseases and COVID-19 pandemic: global Perspective and Indian Scenario.
Ann Med Surg (Lond). 2023 Jul 7;85(8):3997-4004. doi: 10.1097/MS9.0000000000001057. eCollection 2023 Aug.
3
Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.
mSphere. 2020 Jul 8;5(4):e00602-20. doi: 10.1128/mSphere.00602-20.
4
Nipah Virus: Past Outbreaks and Future Containment.
Viruses. 2020 Apr 20;12(4):465. doi: 10.3390/v12040465.
5
Major zoonotic diseases of public health importance in Bangladesh.
Vet Med Sci. 2021 Jul;7(4):1199-1210. doi: 10.1002/vms3.465. Epub 2021 Mar 2.
6
The novel zoonotic COVID-19 pandemic: An expected global health concern.
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
7
Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India.
Ann Med Surg (Lond). 2022 Jul;79:103972. doi: 10.1016/j.amsu.2022.103972. Epub 2022 Jun 15.
9
Outbreak of an emerging zoonotic Nipah virus: An emerging concern.
J Biosaf Biosecur. 2023 Jun;5(2):57-59. doi: 10.1016/j.jobb.2023.04.002. Epub 2023 Apr 25.

引用本文的文献

2
Nipah virus: pathogenesis, genome, diagnosis, and treatment.
Appl Microbiol Biotechnol. 2025 Jul 1;109(1):158. doi: 10.1007/s00253-025-13474-6.
3
Evaluation of country preparedness for Nipah and avian influenza zoonotic viral threats in Bangladesh.
One Health. 2025 May 17;20:101075. doi: 10.1016/j.onehlt.2025.101075. eCollection 2025 Jun.
4
Nipah virus: Preventing the next outbreak.
World J Clin Cases. 2025 Apr 16;13(11):99748. doi: 10.12998/wjcc.v13.i11.99748.
8
The Current Pathogenicity and Potential Risk Assessment of Nipah Virus as Potential Cause of "Disease X": A Narrative Review.
Health Sci Rep. 2024 Dec 4;7(12):e70241. doi: 10.1002/hsr2.70241. eCollection 2024 Dec.
9
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
BMJ Glob Health. 2024 Apr 30;9(4):e014386. doi: 10.1136/bmjgh-2023-014386.

本文引用的文献

1
COVID-19: A Risk Assessment Perspective.
J Chem Health Saf. 2020 May 11;27(3):160-169. doi: 10.1021/acs.chas.0c00035. eCollection 2020 May 26.
2
Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel?
SN Appl Sci. 2021;3(1):110. doi: 10.1007/s42452-020-04051-9. Epub 2021 Jan 11.
3
COVID-19 vaccination in immunocompromised patients.
Clin Rheumatol. 2021 Feb;40(2):797-798. doi: 10.1007/s10067-020-05547-w. Epub 2021 Jan 11.
4
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
EMBO Mol Med. 2021 Jan 11;13(1):e13105. doi: 10.15252/emmm.202013105. Epub 2020 Nov 3.
5
Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.
mSphere. 2020 Jul 8;5(4):e00602-20. doi: 10.1128/mSphere.00602-20.
6
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3.
7
Zoonoses: beyond the human-animal-environment interface.
Lancet. 2020 Jul 4;396(10243):1. doi: 10.1016/S0140-6736(20)31486-0.
8
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.
Mol Cancer. 2020 Jun 2;19(1):100. doi: 10.1186/s12943-020-01218-1.
9
Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.
Encephale. 2020 Jun;46(3):193-201. doi: 10.1016/j.encep.2020.04.005. Epub 2020 Apr 22.
10
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
J Mol Cell Cardiol. 2020 Jul;144:47-53. doi: 10.1016/j.yjmcc.2020.04.031. Epub 2020 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验